Abstract:Recently several low-grade renal cell tumors, distinct from those recognized by the 2004 World Health Organization classification of renal tumors, have been described. These tumors had similar clinicopathologic features, being low-stage tumors with cystic, tubuloacinar, and/or papillary architecture. The tumor cells were low grade with variable amounts of clear cytoplasm that was positive for cytokeratin 7 (CK7), but negative for CD10. Genetic changes characteristic of clear cell or papillary renal cell carcinoma were not seen in these tumors. We investigated the morphologic, immunohistochemical, and genetic features of 36 additional tumors. Immunohistochemistry was carried out for CK7, carbonic anhydrase 9, α-methylacyl-CoA racemase, CD10, TFE-3, and desmin. Interphase fluorescence in situ hybridization was carried out with centromeric probes for chromosomes 3, 7, 17, and a subtelomeric probe for 3p25. Sequencing of von Hippel-Lindau gene and analysis of the methylation status of the promoter region was also carried out in 2 tumors. Thirty-six tumors from 33 patients (mean age: 60.4 , range: 26 to 88; 17 men and 16 women) were studied. Three patients had bilateral tumors and 1 patient had von Hippel-Lindau disease. Follow-up was available in 60% (20/33) of the patients for a mean of 27.4 (range 1 to 85) months. No patient had evidence of the disease after surgery except for the patient with von Hippel-Lindau disease, who was alive with stable disease in the contralateral kidney. All 36 tumors were small (mean size 2.4 cm; range 0.9 to 4.5 cm) and low stage (pT1). The majority was cystic and had prominent fibrous capsule and stroma. The tumors were composed of variable amount of cysts, papillae, tubules, acini, and solid nests. The most characteristic histologic features were branching tubules and acini and anastomosing clear cell ribbons with low-grade nuclei. All tumors were strongly positive for CK7 and variably positive for CA9, but largely negative for CD10, and negative for α-methylacyl-CoA racemase and TFE-3. All but 1 tumor had no gains of chromosomes 7 and 17 and deletion of 3p. Only 1 tumor had low copy number gains of chromosomes 7 and 17. VHL gene mutation and promoter methylation were negative in 2 tumors analyzed. We show that these tumors, which we term as “clear cell tubulopapillary renal cell carcinoma,” constitute a unique subtype in the spectrum of renal epithelial neoplasia based on their characteristic morphologic and immunohistochemical features.

Tubulocystic Renal Cell Carcinoma Of The Kidney: A Clinical, Pathological, Immunohistochemical, And Fluorescence In Situ Hybridization Study

Cystic renal cell carcinoma: a report of 67 cases including 4 cases with concurrent renal cell carcinoma

Tubulocystic Carcinoma of the Kidney: Clinicopathologic and Molecular Characterization

Tubulocystic renal cell carcinoma: Two-case report and literature review

Clinicopathological features of renal cell tumor: an analysis of 229 cases

[Clear Cell Papillary Renal Cell Carcinoma: a Distinct Low-Grade Renal Tumour].

Clinical features of tubulocystic carcinoma of the kidney:A case report with literature review

Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.

Clear Cell Tubulopapillary Renal Cell Carcinoma: A Study of 36 Distinctive Low-grade Epithelial Tumors of the Kidney

Clear Cell Papillary Renal Cell Carcinoma: a Clinicopathological Study Emphasizing Ultrastructural Features and Cytogenetic Heterogeneity.

Renal Cell Carcinomas with T(6;11)(p21;q12) Presenting with Tubulocystic Renal Cell Carcinoma-Like Features.

Cystic Renal Cell Carcinoma:Analysis of Biologic Characteristics,clinical Features and Prognosis

Clinical features and survival analysis of clear cell papillary renal cell carcinoma: A 10-year retrospective study from two institutions.

Multimodal imaging findings of tubulocystic renal cell carcinoma: A case report

Clinicopathologic Study of Renal Cell Carcinoma with Rhabdoid Features

[Clinicopathologic Features of Clear Cell Papillary Renal Cell Carcinoma].

Multilocular cystic renal clear cell carcinoma

Fumarate Hydratase–Deficient Renal Cell Carcinoma With Predominant Tubulocystic Features Mimics Tubulocystic Renal Cell Carcinoma

Clinicopathologic features and molecular genetic analysis of multilocular cystic renal cell carcinoma]

Multilocular Cystic Renal Cell Neoplasm of Low Malignant Potential: A Series of 76 Cases.

The clinical and pathological manifestations of papillary renal cell carcinoma